Search the Newsroom
Filter By
Showing 2631 - 2640 of 2779 results
Poison Control Center Participates in Medical Toxicology Day
On Nov. 5, 2014, The Poison Control Center at The Children’s Hospital of Philadelphia and Einstein Healthcare Network hosted a city-wide Medical Toxicology Day.
Classification of Gene Mutations in a Children’s Cancer May Point to Improved Treatments
CHOP and Penn Medicine experts are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations, setting the stage for a phase 3 clinical trial.
Stay or Go? When to Keep Your Child Home From School
Nothing throws a monkey wrench into your day like a child waking up feeling sick. But before you cancel your meetings and call out for carpool assistance, know that not every cough and sniffle means your child should stay home from school.
Technically Speaking: Know the “7 Rights” of Vaccine Administration
Unfortunately, it is all too easy to make a vaccine administration error. And even more unfortunately, the error is likely impossible to undo. So be careful to do the “right” thing the first time.
CHOP and Temple Receive NIH Grant to Explore Eradicating HIV From Hiding Places in the Brain
CHOP and Temple share a $4.3 million NIH grant to explore new tools to eradicate HIV lurking in brain cells despite current antiviral treatments.
Steadily Rising Increases in Mitochondrial DNA Mutations Cause Abrupt Shifts in Disease
Subtle changes in mitochondria, our cells’ power plants, may trigger a broad range of common diseases, says a pioneering CHOP scientist.
Mystery Rash on Foot Spreads to Hands, Arms, Legs, Head, Trunk
Read a case study about a 14-year-old boy presented to Urgent Care for a skin lesion on his right foot, which had been present for 3 weeks.
X-Ray Elevates Diagnosis from Pneumonia to Hodgkin’s Lymphoma
Read a case study about a previously healthy 12-year-old boy presented to CHOP Urgent Care with fever and nonproductive cough.
Personalized Cellular Therapy Achieves Complete Remission in 90 Percent of Acute Lymphoblastic Leukemia Patients Studied
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) went into remission after receiving an investigational therapy, CTL019.
2014 Parkway Run & Walk Raises $1,275,000
Thanks to the support of our donor community, the 2014 Four Seasons Parkway Run & Walk raised $1,275,000 for pediatric cancer research and care at CHOP. Watch the video of this year's event.